References
- Reya T, Clevers H. Wnt signalling in stem cells and cancer. Nature 2005; 434:843-50; PMID:15829953; http://dx.doi.org/10.1038/nature03319
- Bajaj J, Zimdahl B, Reya T. Fearful Symmetry: Subversion of asymmetric division in cancer development and progression. Cancer Res 2015; 75:792-797; PMID:25681272; http://dx.doi.org/10.1158/0008-5472.CAN-14-2750
- Quyn AJ, Appleton PL, Carey FA, Steele RJC, Barker N, Clevers H, Ridgway RA, Sansom OJ, Näthke IS. Spindle orientation bias in gut epithelial stem cell compartments is lost in precancerous tissue. Cell Stem Cell 2010; 6:175-181; PMID:20144789; http://dx.doi.org/10.1016/j.stem.2009.12.007
- Qu Y, Gharbi N, Yuan X, Olsen JR, Blicher P, Dalhus B, Brokstad KA, Lin B, Øyan AM, Zhang W, et al. Axitinib blocks Wnt/β-catenin signaling and directs asymmetric cell division in cancer. Proc Natl Acad Sci U S A 2016; 113:9339-44; PMID:27482107; http://dx.doi.org/10.1073/pnas.1604520113
- Conboy MJ, Karasov AO, Rando TA. High incidence of non-random template strand segregation and asymmetric fate determination in dividing stem cells and their progeny. PLoS Biol 2007; 5:e102; PMID:17439301; http://dx.doi.org/10.1371/journal.pbio.0050102
- Hu-Lowe DD, Zou HY, Grazzini ML, Hallin ME, Wickman GR, Amundson K, Chen JH, Rewolinski DA, Yamazaki S, Wu EY, et al. Nonclinical antiangiogenesis and antitumor activities of Axitinib (AG-013736), an oral, potent, and selective inhibitor of vascular endothelial growth factor receptor tyrosine kinases 1, 2, 3. Clin Cancer Res 2008; 14:7272-7283; PMID:19010843; http://dx.doi.org/10.1158/1078-0432.CCR-08-0652
- Hopkins AL. Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol 2008; 4:682-690; PMID:18936753; http://dx.doi.org/10.1038/nchembio.118